American Century Companies’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
VCM
WA
SCM
SCM
American Century Companies's CCCC Position: Q2 2026 in Review
American Century Companies increased its C4 Therapeutics (CCCC) stake by 76% in Q2 2026, buying an estimated $223K and bringing the position to 150,681 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.
American Century Companies first reported a position in CCCC in Q4 2022 and has held it in 14 quarters since. The position peaked at $726K in Q1 2024. 85 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.
- American Century Companies held 150,681 shares of C4 Therapeutics worth $704K as of Q2 2026.
- American Century Companies bought 65,237 C4 Therapeutics shares in Q2 2026, an estimated $223K.
- C4 Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2509 holding.
- American Century Companies first reported a position in C4 Therapeutics in Q4 2022 and has held it in 14 quarters since.
- American Century Companies's C4 Therapeutics position peaked at $726K in Q1 2024.
- 85 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.